The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions

By  

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1458-1465

Bentham Science Publishers

Access to resources Recommend Favorite

HPV-16 vaccine reduces incidence of HPV infections and cervical neoplasia

By  

Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite

HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers

By Manzo-Merino Joaquin   Thomas Miranda   Fuentes-Gonzalez Alma M   Lizano Marcela   Banks Lawrence  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1357-1368

Informa Healthcare

Access to resources Recommend Favorite

HPV 16/18 vaccine prevents cervical intraepithelial neoplasia

By  

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite